9997 — Kangji Medical Holdings Balance Sheet
0.000.00%
- HK$8.78bn
- HK$7.46bn
- CNY1.01bn
- 73
- 45
- 94
- 84
Annual balance sheet for Kangji Medical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,782 | 3,014 | 2,830 | 2,688 | 1,243 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 88.6 | 82.7 | 175 | 229 | 272 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,930 | 3,168 | 3,124 | 3,381 | 2,064 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 88.2 | 108 | 270 | 286 | 275 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3,020 | 3,390 | 3,985 | 4,264 | 2,918 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 75.4 | 117 | 154 | 191 | 261 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 83.7 | 130 | 612 | 614 | 289 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 2,937 | 3,260 | 3,373 | 3,650 | 2,629 |
Total Liabilities & Shareholders' Equity | 3,020 | 3,390 | 3,985 | 4,264 | 2,918 |
Total Common Shares Outstanding |